Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
Zeynep Kalender Atak1,2, Hana Imrichova1,2, Dmitry Svetlichnyy1,2
1Laboratory of Computational Biology, VIB Center for Brain & Disease Research, Leuven, Belgium.
Abstract:
The identification of functional non-coding mutations is a key challenge in the field of genomics. Here we introduce μ-cisTarget to filter, annotate and prioritize cis-regulatory mutations based on their putative effect on the underlying "personal" gene regulatory network. We validated μ-cisTarget by re-analyzing the TAL1 and LMO1 enhancer mutations in T-ALL, and the TERT promoter mutation in melanoma. Next, we re-sequenced the full genomes of ten cancer cell lines and used matched transcriptome data and motif discovery to identify master regulators with de novo binding sites that result in the up-regulation of nearby oncogenic drivers. μ-cisTarget is available from http://mucistarget.aertslab.org .
Insights
Identifying functional non-coding mutations is crucial. Our tool, μ-cisTarget, filters and prioritizes these mutations by analyzing their impact on personal gene regulatory networks, aiding cancer driver discovery.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Functional non-coding mutations are challenging to identify.
- Understanding their impact on gene regulation is critical for disease insights.
Purpose of the Study:
- Introduce μ-cisTarget, a novel tool for filtering, annotating, and prioritizing cis-regulatory mutations.
- Assess the effect of mutations on personal gene regulatory networks.
Main Methods:
- Utilized μ-cisTarget to analyze known mutations in T-ALL and melanoma.
- Performed whole-genome sequencing on ten cancer cell lines.
- Integrated transcriptome data and motif discovery to identify master regulators and de novo binding sites.
Main Results:
- Successfully validated μ-cisTarget on established cancer mutation datasets.
- Identified master regulators with de novo binding sites driving oncogene upregulation in cancer cell lines.
Conclusions:
- μ-cisTarget provides a robust method for prioritizing functional cis-regulatory mutations.
- The tool aids in uncovering novel cancer driver mechanisms by linking mutations to gene expression changes.
Related Concept Videos
Cis-regulatory Sequences
Cis-regulatory Sequences
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

